Quarter Ended Jun 30, 2022
Net sales were $104.2 million compared to $109.0 million.
GAAP net income was $1.0 million, or $0.03 per diluted share, compared to $6.8 million, or $0.32 per diluted share.
Adjusted EBITDA was $9.0 million compared to $13.4 million.
Nature’s Sunshine provides over 600 products across the globe, investing in the people and world around us. No one obsesses over results like we do, and we have prioritized our environmental, social and governance efforts to become a company our shareholders can depend on. Join us as we take health to new heights.View ESG
Geographic segments: Asia, Europe, North America and Latin America/Other
Product lines: General Health, Immune, Cardiovascular, Digestive, Personal Care and Weight Management
Employees, as of December 31, 2021
As of Dec. 31, 2021 • 10-K 2021